| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |